01 August 2005
The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
Anna Kunsdorf-Wnuk, Ewa Marzec-Lewenstein, Danuta Arct-Danielak, Ewa Musioł, Romuald Bohatyrewicz, Rafał BechtMed Sci Monit 2005; 11(8): CS49-55 :: ID: 202172
Abstract
Background: Treatment of hemopoietic system neoplasias involves severecomplications associated with immunosuppression. We present two cases of treating severe sepsis utilizingrecombinant human activated protein C (rhAPC) in the course of bilateral pneumonia in patients with hairycell leukemia (HCL) and T-cell acute lymphoblastic leukemia (ALL). RhAPC, limited the coagulation cascadeby inactivating FVa and FVIIIa, directly and indirectly limiting systemic inflammatory response syndrome(SIRS), and improved the fibrinolysis process. These actions break the pathomechanism of sepsis and improvesurvival. Case Report: Besides intensive, multidirectional treatment of severe sepsis, Xigris (activateddrotrecogin alfa) was administered on the second day in both cases. The infusion continued, as recommended,for 96 hours without complications. During treatment the patients' general condition and respiratoryefficiency improved, allowing respirator weaning on days 5 and 8 of therapy. These cases of severe sepsisand immunosuppression indicate a high therapeutic efficacy of drotrecogin alfa (activated). Treatmentoutcome was uncertain because of the patients' hematological condition, so rapid restoration of respiratoryefficiency and no disease progression after discontinuing treatment was a great success, possibly dueto implementing Xigris at a relatively early stage of sepsis and the intensive therapy conducted accordingto Surviving Sepsis Campaign guidelines. Conclusions: Patient survival in severe sepsis directly dependson early diagnosis and institution of treatment. 1. These cases confirm the effectiveness of drotrecoginalfa in severe sepsis as part of multidirectional therapy. 2. Microorganisms causing atypical pneumoniashould be considered in diagnosing infections in patients treated with cytostatic agents.
Keywords: Leukemia, Lymphocytic, Acute - complications, Enzyme Activation, Immune Tolerance, Leukemia, Hairy Cell - therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy, Protein C - therapeutic use, Recombinant Proteins - therapeutic use, Sepsis - drug therapy
Editorial
01 May 2022 : Editorial
Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19DOI: 10.12659/MSM.937048
Med Sci Monit 2022; 28:e937048
SARS-CoV-2/COVID-19
04 May 2022 : Clinical Research
Effects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...Med Sci Monit In Press; DOI: 10.12659/MSM.936069
22 April 2022 : Clinical Research
Factors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)Med Sci Monit In Press; DOI: 10.12659/MSM.936547
27 April 2022 : Meta-Analysis
Effect of the COVID-19 Pandemic on Serum Vitamin D Levels in People Under Age 18 Years: A Systematic Review...Med Sci Monit In Press; DOI: 10.12659/MSM.935823
06 May 2022 : Clinical Research
COVID-19: Another Cause of Dental Anxiety?Med Sci Monit 2022; 28:e936535
In Press
19 May 2022 : Clinical Research
Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with ...Med Sci Monit In Press; DOI: 10.12659/MSM.936323
18 May 2022 : Clinical Research
Physical and Psychosocial Concept Domains Related to Health-Related Quality of Life (HRQL) in 50 Girls and ...Med Sci Monit In Press; DOI: 10.12659/MSM.936801
18 May 2022 : Clinical Research
Association Between Variants of the Mannose-Binding Lectin 2 Gene and Susceptibility to Sepsis in the Haina...Med Sci Monit In Press; DOI: 10.12659/MSM.936134
17 May 2022 : Clinical Research
Clinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Sol...Med Sci Monit In Press; DOI: 10.12659/MSM.936368
Most Viewed Current Articles
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review article
Long-Term Respiratory and Neurological Sequelae of COVID-19DOI :10.12659/MSM.928996
Med Sci Monit 2020; 26:e928996
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952